Push launch MHRA approves GLP –1 receptor agonist semaglutide to lessen danger of serious heart issues in obese or overweight Grownups Semaglutide is the first weightloss drug accredited in britain as being a preventative therapy for the people with established cardiovascular diseaseMany recent experiments have revealed us that semaglutide is an … Read More